Molecular basis of pancreatic cancer - Selected issues

Gastrointestinal Oncology

Volumn 4, Issue 2-3, 2002, Pages 147-152

  Talar Wojnarowska, Renata ^a   Sasor, Agata ^a   Strzelczyk, Janusz ^a   Małecka Panas, Ewa ^a  

^a MEDICAL UNIVERSITY OF LODZ   (Poland)

Author keywords

Apoptosis; Molecular basis; Pancreatic cancer; Proliferation

Indexed keywords

CYCLIN D1; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY KI 67; PROTEIN BAX; PROTEIN BCL 2; PROTEIN P53;

ADULT; AGED; APOPTOSIS; CELL PROLIFERATION; CLINICAL ARTICLE; CONFERENCE PAPER; FEMALE; GENE OVEREXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; PANCREAS CANCER; PANCREAS RESECTION; PANCREATICODUODENECTOMY; PRIORITY JOURNAL; TUMOR SUPPRESSOR GENE;

EID: 0036663925     PISSN: 1475956X     EISSN: None     Source Type: Journal    
DOI: 10.1080/1475956021000020206     Document Type: Conference Paper

References (46)

1. Parker, S.L., Tond, T. and Bolden, S. (1997) "Cancer statistics", CA Cancer J. Clin. 47, 5-27.
2. Almoguera, C., Shibato, D., Forrester, K., Martin, J., Arnheim, N. and Perucho, M. (1988) "Most human carcinomas of the exocrine pancreas contain c-K ras gene mutations", Cell 53, 549-554.
3. Kondo, H., Sugano, K., Fukayama, N., Kyogoku, A., Nose, H., Shimada, K., Ohkura, H. and Ohtsu, A. (1994) "Detection of point mutations in the Ki-ras oncogene at codon 12 in pure pancreatic juice for diagnosis of pancreatic cancer", Cancer 73, 1589-1594.
4. Van Laethem, J.L., Vertongen, P., Deviere, J., Van Rampelbergh, J., Rickaert, F., Cremer, M. and Robberecht, P. (1995) "Detection of c-Ki-ras gene codon 12 mutations from pancreatic duct brushings in the diagnosis of pancreatic tumours", Gut 36, 781-787.
5. Tada, M., Ohashi, M. and Shiratori, Y. (1996) "Analysis of K-ras gene mutations in hyperplastic duct cells of the pancreas without pancreatic diseases", Gastroenterology 110, 227-231.
6. Motojima, K., Tsunoda, T., Kanematsu, T., Nagata, Y., Urano, T. and Shiku, H. (1991) "Distinguishing pancreatic carcinoma from periampullary carcinomas by analysis of mutations in the Kirstenras oncogene", Ann. Surg. 214, 657-662.
7. Levine, A., Momand, J. and Finlaz, C. (1991) "The p53 tumor suppressor gene", Nature 351, 453-456.
8. Gazzaniga, G.M., Papadia, F.S., Dezzana, M., Cappato, S., Filauro, M. and Bandellani, R. (2001) "Role of p53 mutations on survival after pancreatoduodenectomy for ductal adenocarcinoma of the pancreatic head", Hepatogastroenterology 48, 1743-1745.
9. Su, H.G. and Kern, S.E. (2000) "Molecular genetics of ductal pancreatic neoplasia", Curr. Opin. Gastroenterol. 16, 419-425.
10. Inoue, S., Tezel, E. and Nakao, A. (2001) "Molecular diagnosis in pancreatic cancer", Hepatogastroenterology 48, 933-938.
11. Scarpa, A., Moore, P.S., Rigaud, G. and Zamboni, G. (2000) "Genetic anomalies of pancreatic cancer", In: Devenis, C.G. and Bassi, C., eds, Pancreatic Tumors (Georg Thieme, Stuttgart) pp. 37-49.
12. Hruban, R.H., Wilenz, R.E. and Kern, S.E. (2000) "Genetic progression in the pancreatic ducts", Am. J. Pathol. 156, 1821-1825.
13. Hilgers, W. and Kern, S.E. (1999) "Molecular genetic basis of pancreatic adenocarcinoma", Genes Chromosomes Cancer 26, 1-12.
14. Hengartner, M.O. (2000) "The biochemistry of apoptosis", Nature 407, 770-776.
15. Green, D.R. and Reed, J.C. (1998) "Mitochondria et apoptosis", Science 281, 1309-1312.
16. Korsmeyer, S.J. (1992) "Bcl-2 initiates a new category of oncogenes: Regulators of cell death", Blood 80, 879-886.
17. Friess, H., Lu, Z., Graber, H.U., Zimmermann, A., Adler, G., Korc, M., Schmid, R.M. and Buchler, M.W. (1998) "Bax, but not bcl-2, influences the prognosis of human pancreatic cancer", Gut 43, 414-421.
18. Pines, J. (1994) "Protein kinases and cell cycle control", Semin. Cell Biol. 5, 399-408.
19. Sherr, C.J. (1994) "G1 phase progression: Cyclin on cue", Cell 79, 551-555.
20. Kornmann, M., Ishiwata, T., Arber, N., Beger, G.H. and Korc, M. (1998) "Increased cyclin D1 expression in chronic pancreatitis", Pancreas 17, 158-162.
21. McIntosh, G.G., Anderson, J.J. and Milton, I. (1995) "Determination of the prognostic value of cyclin D1 overexpression in breast cancer", Oncogene 11, 885-891.
22. Arber, N., Doki, Y. and Han, E.K.-H. (1997) "Antisense to cyclin D1 inhibits the growth and tumorigenicity of human colon cancer cells", Cancer Res. 57, 1569-1574.
23. Zhou, P., Jiang, W. and Zhang, Y.J. (1995) "Antisense to cyclin D1 inhibits growth and reverses the transformed phenotype of human oesophageal cancer cells", Oncogene 11, 571-580.
24. Malecka-Panas, E., Nevalainen, T., Kordek, R., Sasor, A., Strzelczyk, J., Janiak, A., Papierz, W. and Drzewoski, J. (2000) "Cyclin D1, p53, EGF-R and Ki-67 expression in pancreatic adenocarcinoma (PA) and chronic pancreatitis (CP)", Pancreas 21, 459, (Abstract) Joint Meeting of the American Pancreatology Association and the International Association of Pancreatologists, 1-5 November 2000, Chicago, USA.
25. Gansauge, S., Gansauge, F., Ramadani, M., Stobbe, B., Rau, N., Harada, N. and Beger, H.G. (1997) "Overexpression of cyclin D1 in human pancreatic carcinoma is associated with poor prognosis", Cancer Res. 57, 1634-1637.
26. Friess, H., Berberat, P. and Schilling, M. (1996) "Pancreatic cancer: The potential clinical relevance of alterations in growth factors and their receptors", J. Mol. Med. 74, 35-42.
27. Friess, H., Yamanaka, Y., Buchler, M., Gold, L.I. and Korc, M. (1993) "Enhanced expression of transforming growth factor beta isoforms in pancreatic cancer correlates with decrease survival", Gastroenterology 105, 1846-1852.
28. Ozawa, F., Friess, H., Templa-Callera, A., Kleef, J. and Buchler, W. (2001) "Growth factors and their receptors in pancreatic cancer", Teratog. Carcinog. Mutagen. 21, 27-44.
29. Gold, L.I. and Korc, M. (1994) "Expression of transforming growth factor β 1, 2 and 3 mRNA and protein in human cancers", Dig. Surg. 11, 150-156.
30. Małecka-Panas, E., Meah, N., Relan, N.K. and Majumdar, A.P.N. (1996) "Increased activation of EGF-receptor tyrosine kinase by EGF and TGF-alpha in the colonic mucosa of aged rats", J. Gerontol. A Biol. Sci. Med. 51, B60-B65.
31. Raymond, E., Faivre, S. and Armand, J.P. (2000) "Epidermal growth factor receptor tyrosine kinase as a target for anticancer therapy", Drug 60, 15-23.
32. Małecka-Panas, E., Filgiel, S., Meah, N., Dinda, J., Dutta, S. and Majumdar, A.P.N. (1996) "Azoxymethane enhances ligand-induced activation of EGF-receptor tyrosine kinase in the colonic mucosa of rats", Carcinogenesis 17(2), 233-237.
33. Yamanaka, Y., Friess, H., Buchler, M., et al. (1993) "Overexpression of acidic and basic fibroblast growth factors in human pancreatic cancer correlates with advanced tumor stage", Cancer Res. 53, 5289-5295.
34. Zhu, Z., Friess, H., diMola, F.F., et al. (1999) "Nerve growth factor expression correlates with perineural invasion and pain in human pancreatic cancer", J. Clin. Oncol. 17, 2419-2424.
35. Bergmann, U., Funatomi, H., Yokoyama, M., Beger, H.G. and Korc, M. (1995) "Insulin-like growth factor I overexpression in human pancreatic cancer; evidence for autocrine and paracrine roles", Cancer Res. 55, 2007-2012.
36. Andren-Sandberg, A., Dervenis, C. and Lowenfels, B. (1997) "Etiologic links between chronic pancreatitis and pancreatic cancer", Scand. J. Gastroenterol. 32, 97-103.
37. Ebert, M., Schandl, L. and Schmid, R.M. (2001) "Differentiation of chronic pancreatitis from pancreatic cancer: Recent advances in molecular diagnosis", Dig. Dis. 19, 32-36.
38. Gansauge, S., Schmid, R.M., Muller, J., Adler, G., Mattfeld, T. and Beger, H.G. (1998) "Genetic alterations in chronic pancreatitis: Evidence for early occurrence of p53 but not K-ras mutations", Br. J. Surg. 85(3), 337-340.
39. Rivera, J.A., Rall, C.I., Graeme-Cook, F., Fernandez-del Castillo, C., Shu, P., Lakey, N., Tepper, R., Rattner, D.W., Warshaw, A.L. and Rustgi, A.K. (1997) "Analysis of K-ras oncogene mutations in chronic pancreatitis with ductal hyperplasia", Surgery 121, 42-49.
40. Gold, E.O. and Cameron, J.L. (1993) "Chronic pancreatitis and pancreatic cancer", N. Engl. J. Med. 328, 1485-1486.
41. Fernandez, E., LaVecchia,C., Porta,M., Negri, E.,d'Avanzo, B. and Boyle, P. (1995) "Pancreatitis and the risk of pancreatic cancer", Pancreas 11, 185-189.
42. Senzatimore, S. and Barkin, J.S. (1993) "Chronic pancreatitis and pancreatic cancer: A slow-burning wick or an explosive event?", N. Engl. J. Med. 328, 1593-1594.
43. Chari, S.T., Mohan, V., Pitchumoni, C.S., Viswanathan, M., Madanagopalan, N. and Lowenfels, A.B. (1994) "Risk of pancreatic carcinoma in tropical calcifying pancreatitis: An epidemiological study", Pancreas 9, 62-66.
44. Misra, S.P., Thorat, V.K., Vij, J.C. and Anend, B.S. (1990) "Development of carcinoma in chronic calcific pancreatitis", Int. J. Pancreatol. 6, 307-312.
45. Tomaszewska, R., Okofi, K., Nowak, K. and Stachura, J. (1998) "Her-2/neu expression as a progression marker in pancreatic intraepithelial neoplasia", Pol. J. Pathol. 49, 83-92.
46. Dugan, M.C., Dergham, S.T., Kucway, R., Singh, K., Biernat, L., Du, W., Vaitikevicius, V.K., Crissman, J.D. and Sarkar, F.H. (1997) "HER-2/neu expression in pancreatic adenocarcinoma: Relation to tumor differentiation and survival", Pancreas 14(3), 229-236.